Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Dipeptidyl Peptidase 4 Inhibitor [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
SITAGLIPTIN	19,904	2,412	12.1%	6,668	1,347	67.3 yrs	52.3%
LINAGLIPTIN	7,762	726	9.4%	2,794	405	70.2 yrs	51.8%
SAXAGLIPTIN	2,468	263	10.7%	838	145	65.5 yrs	47.8%
ALOGLIPTIN	1,385	122	8.8%	567	71	69.0 yrs	41.0%

Head-to-Head Comparisons

SITAGLIPTIN vs LINAGLIPTIN SITAGLIPTIN vs SAXAGLIPTIN SITAGLIPTIN vs ALOGLIPTIN LINAGLIPTIN vs SAXAGLIPTIN LINAGLIPTIN vs ALOGLIPTIN SAXAGLIPTIN vs ALOGLIPTIN

← Back to Dipeptidyl Peptidase 4 Inhibitor [EPC] Class side effects →